LAG-3 has been found to be expressed on tumor-infiltrating T cells in PC, and its expression is associated with poor disease outcomes Consequently, clinical studies are investigating the inhibitory effect of LAG-3 in solid cancers (Maruhashi et al., 2020; Li et al., 2021; Seifert et al., 2021). This evidence concerns the gene LAG3 and neoplasm.